Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Thill

Showing results (71-80 of 165) with videos related to

Pageof 17
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 28, 2020
Patient reported outcome and cosmetic evaluation following implant-based breast-reconstruction with a titanized polypropylene mesh (TiLOOP® Bra): A prospective clinical study in 269 patientsMarc Thill, Andree Faridi, Anette Meiré, et al.
Oncology Letters|October 5, 2016
Expression of cyclooxygenase-2 in cervical cancer is associated with lymphovascular invasionFriederike Hoellen, Annika Waldmann, Constanze Banz-Jansen, et al.
Breast (Edinburgh, Scotland)|April 4, 2026
Optimizing axillary lymph node management in early-stage HR+/HER2- breast cancer: Practical strategies for enhanced detection ratesMarc Thill, Maria-João Cardoso, Carmen Criscitiello, et al.
Breast Care (Basel, Switzerland)|April 7, 2016
ABC3 Consensus: Assessment by a German Group of ExpertsChristoph Thomssen, Doris Augustin, Johannes Ettl, et al.
Molecular and Clinical Oncology|November 29, 2017
Claudin-1 expression in cervical cancerFriederike Hoellen, Annika Waldmann, Constanze Banz-Jansen, et al.
Breast Cancer Research and Treatment|June 14, 2024
The REMAR (Rhein-Main-Registry) real-world study: prospective evaluation of the 21-gene breast recurrence score® assay in addition to Ki-67 for adjuvant treatment decisions in early-stage breast cancerChristian Jackisch, Louiza Anastasiadou, Sebastian Aulmann, et al.
Frontiers in Oncology|May 3, 2024
App-based support for breast cancer patients to reduce psychological distress during therapy and survivorship - a multicentric randomized controlled trialJosefine Wolff, Svenja Seidel, Pia Wuelfing, et al.
Breast (Edinburgh, Scotland)|September 10, 2023
Anti-hormonal maintenance treatment with the CDK4/6 inhibitor ribociclib after 1st line chemotherapy in hormone receptor positive / HER2 negative metastatic breast cancer: A phase II trial (AMICA)Thomas Decker, Kerstin Lüdtke-Heckenkamp, Luidmila Melnichuk, et al.
BMC Cancer|August 27, 2018
RESPONDER - diagnosis of pathological complete response by vacuum-assisted biopsy after neoadjuvant chemotherapy in breast Cancer - a multicenter, confirmative, one-armed, intra-individually-controlled, open, diagnostic trialJoerg Heil, Peter Sinn, Hannah Richter, et al.
Eclinicalmedicine|December 2, 2022
Patient-reported outcomes for the Intergroup Sentinel Mamma study (INSEMA): A randomised trial with persistent impact of axillary surgery on arm and breast symptoms in patients with early breast cancerToralf Reimer, Angrit Stachs, Kristina Veselinovic, et al.
Pageof 17

Showing results (71-80 of 165) with videos related to

Sort By:
Pageof 17
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 28, 2020
Patient reported outcome and cosmetic evaluation following implant-based breast-reconstruction with a titanized polypropylene mesh (TiLOOP® Bra): A prospective clinical study in 269 patientsMarc Thill, Andree Faridi, Anette Meiré, et al.
Oncology Letters|October 5, 2016
Expression of cyclooxygenase-2 in cervical cancer is associated with lymphovascular invasionFriederike Hoellen, Annika Waldmann, Constanze Banz-Jansen, et al.
Breast (Edinburgh, Scotland)|April 4, 2026
Optimizing axillary lymph node management in early-stage HR+/HER2- breast cancer: Practical strategies for enhanced detection ratesMarc Thill, Maria-João Cardoso, Carmen Criscitiello, et al.
Breast Care (Basel, Switzerland)|April 7, 2016
ABC3 Consensus: Assessment by a German Group of ExpertsChristoph Thomssen, Doris Augustin, Johannes Ettl, et al.
Molecular and Clinical Oncology|November 29, 2017
Claudin-1 expression in cervical cancerFriederike Hoellen, Annika Waldmann, Constanze Banz-Jansen, et al.
Breast Cancer Research and Treatment|June 14, 2024
The REMAR (Rhein-Main-Registry) real-world study: prospective evaluation of the 21-gene breast recurrence score® assay in addition to Ki-67 for adjuvant treatment decisions in early-stage breast cancerChristian Jackisch, Louiza Anastasiadou, Sebastian Aulmann, et al.
Frontiers in Oncology|May 3, 2024
App-based support for breast cancer patients to reduce psychological distress during therapy and survivorship - a multicentric randomized controlled trialJosefine Wolff, Svenja Seidel, Pia Wuelfing, et al.
Breast (Edinburgh, Scotland)|September 10, 2023
Anti-hormonal maintenance treatment with the CDK4/6 inhibitor ribociclib after 1st line chemotherapy in hormone receptor positive / HER2 negative metastatic breast cancer: A phase II trial (AMICA)Thomas Decker, Kerstin Lüdtke-Heckenkamp, Luidmila Melnichuk, et al.
BMC Cancer|August 27, 2018
RESPONDER - diagnosis of pathological complete response by vacuum-assisted biopsy after neoadjuvant chemotherapy in breast Cancer - a multicenter, confirmative, one-armed, intra-individually-controlled, open, diagnostic trialJoerg Heil, Peter Sinn, Hannah Richter, et al.
Eclinicalmedicine|December 2, 2022
Patient-reported outcomes for the Intergroup Sentinel Mamma study (INSEMA): A randomised trial with persistent impact of axillary surgery on arm and breast symptoms in patients with early breast cancerToralf Reimer, Angrit Stachs, Kristina Veselinovic, et al.
Pageof 17